- $1.10m
- -$3.92m
Annual balance sheet for GRI Bio, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 0.109 | 7.51 | 3.78 | 1.81 | 5.03 |
| Prepaid Expenses | |||||
| Total Current Assets | 0.674 | 8.13 | 4.15 | 2.93 | 5.62 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.281 | 0.206 | — | 0.022 | 0.124 |
| Other Long Term Assets | |||||
| Total Assets | 0.955 | 8.34 | 4.15 | 2.96 | 5.74 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2.23 | 2.44 | 1.81 | 2.7 | 1.64 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 2.41 | 2.52 | 1.81 | 2.7 | 1.71 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -1.45 | 5.82 | 2.34 | 0.259 | 4.03 |
| Total Liabilities & Shareholders' Equity | 0.955 | 8.34 | 4.15 | 2.96 | 5.74 |
| Total Common Shares Outstanding |